科炬生物 (872334.OC)

+ 收藏

利润表(科炬生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年三季报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 12,474,921.4233,499,203.8915,471,709.2733,129,502.3228,076,638.1417,945,043.95
 营业收入(元) 12,474,921.4233,499,203.8915,471,709.2733,129,502.3228,076,638.1417,945,043.95
二、营业总成本(元) 18,404,159.5848,538,192.3322,457,176.5577,083,360.6757,682,808.7533,937,066.02
 营业成本(元) 7,871,301.8822,375,931.138,990,976.1321,480,347.1318,679,792.7311,973,333.17
 研发费用(元) 2,396,080.336,944,139.993,213,595.9311,367,921.748,790,061.975,135,310.09
 营业税金及附加(元) 128,234.04313,339.99143,231.16219,071.36159,623.0882,533.65
 销售费用(元) 4,981,134.5112,150,855.427,188,153.5125,628,738.5717,279,959.4611,755,164.33
 管理费用(元) 2,901,754.866,335,330.442,721,736.4714,530,653.469,865,915.803,269,976.96
 财务费用(元) 125,653.96418,595.36199,483.353,856,628.412,907,455.711,720,747.82
  其中:利息费用(元) 197,197.98524,683.23462,648.554,357,962.28-1,955,233.92
  其中:利息收入(元) 7,271.3837,256.3725,829.2728,915.32-9,818.53
三、其他经营收益
 资产处置收益(元) -47,213.4247,213.42106,485.1223,180.5323,180.53
 资产减值损失(元) --1,312,117.68-546,823.56-703,012.48--
 信用减值损失(元) -424,274.82-8,131,114.01-495,170.65-6,626,766.91-12,791,736.73-131,668.94
 其他收益(元) 215,221.55520,544.72385,821.55977,439.11711,428.35651,417.56
四、营业利润(元) -6,138,291.43-23,914,461.99-7,594,426.52-50,199,713.51-41,663,298.46-15,449,092.92
 加:营业外收入(元) 1,674.54459,092.5762,975.345,818.065,027.581,426.65
 减:营业外支出(元) 11,712.43273,615.13726.0364,805.657,217.807,217.80
五、利润总额(元) -6,148,329.32-23,728,984.55-7,532,177.21-50,258,701.10-41,665,488.68-15,454,884.07
 减:所得税费用(元) ---2,281,606.20-286,053.91-8,175.01
六、净利润(元) -6,148,329.32-23,728,984.55-7,532,177.21-52,540,307.30-41,379,434.77-15,446,709.06
(一)按经营持续性分类
  持续经营净利润(元) -6,148,329.32-23,728,984.55-7,532,177.21-52,540,307.30-41,379,434.77-15,446,709.06
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -6,136,403.11-23,675,100.34-7,511,800.86-52,460,318.34-41,316,333.73-15,432,016.83
  少数股东损益(元) -11,926.21-53,884.21-20,376.35-79,988.96-63,101.04-14,692.23
 扣除非经常性损益后的净利润(元) -6,310,809.22-24,312,501.73-7,932,792.50-53,332,035.53--16,000,502.73
七、每股收益
 一、基本每股收益(元) -0.16-0.64-0.21-1.91-1.55-0.58
 二、稀释每股收益(元) -0.16-0.64-0.21-1.91-1.55-0.58
九、综合收益总额(元) -6,148,329.32-23,728,984.55-7,532,177.21-52,540,307.30-41,379,434.77-15,446,709.06
 归属于母公司所有者的综合收益总额(元) -6,136,403.11-23,675,100.34-7,511,800.86-52,460,318.34-41,316,333.73-15,432,016.83
 归属于少数股东的综合收益总额(元) -11,926.21-53,884.21-20,376.35-79,988.96-63,101.04-14,692.23
公告日期 2024-08-092024-03-152023-08-072023-03-282023-01-102022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院